Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dirocaftor [usan]
2. Pti-808
3. 2g3t6m1as9
4. Dirocaftor (usan)
5. 2137932-23-9
6. 3-quinolinecarboxamide, 1,4-dihydro-n-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-
7. N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
8. Dirocaftor [inn]
9. Unii-2g3t6m1as9
10. Chembl4594297
11. Who 11355
12. Hy-137437
13. Cs-0138638
14. D11781
15. N-[5-hydroxy-2,4-bis(trimethylsilyl)phenyl]-4-oxo-1h-quinoline-3-carboxamide
Molecular Weight | 424.6 g/mol |
---|---|
Molecular Formula | C22H28N2O3Si2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 424.16384583 g/mol |
Monoisotopic Mass | 424.16384583 g/mol |
Topological Polar Surface Area | 78.4 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 681 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
97
PharmaCompass offers a list of Dirocaftor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dirocaftor manufacturer or Dirocaftor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dirocaftor manufacturer or Dirocaftor supplier.
PharmaCompass also assists you with knowing the Dirocaftor API Price utilized in the formulation of products. Dirocaftor API Price is not always fixed or binding as the Dirocaftor Price is obtained through a variety of data sources. The Dirocaftor Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dirocaftor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dirocaftor, including repackagers and relabelers. The FDA regulates Dirocaftor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dirocaftor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dirocaftor supplier is an individual or a company that provides Dirocaftor active pharmaceutical ingredient (API) or Dirocaftor finished formulations upon request. The Dirocaftor suppliers may include Dirocaftor API manufacturers, exporters, distributors and traders.
Dirocaftor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dirocaftor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dirocaftor GMP manufacturer or Dirocaftor GMP API supplier for your needs.
A Dirocaftor CoA (Certificate of Analysis) is a formal document that attests to Dirocaftor's compliance with Dirocaftor specifications and serves as a tool for batch-level quality control.
Dirocaftor CoA mostly includes findings from lab analyses of a specific batch. For each Dirocaftor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dirocaftor may be tested according to a variety of international standards, such as European Pharmacopoeia (Dirocaftor EP), Dirocaftor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dirocaftor USP).